US-Google face off as ad tech antitrust trial comes to close
In conclusion, the Barnyard Chic trend is a celebration of the beauty found in the everyday and the unexpected. By embracing the raw and honest elements of farm life and blending them with high fashion sensibilities, designers have created a trend that is both timeless and fresh. So, embrace your inner farmer, mix your denim with lace, and strut your stuff down the runway in true Barn Wind style.
And just when their opponents thought they had a chance to claw their way back into the game, Zeng Fanbo and Solomon struck again. This time, it was a combination of skill and strategy that proved to be their undoing. With impeccable ball movement and quick decisions, the two players were able to create open shooting opportunities for themselves and their teammates, effectively sealing the victory for Beijing.SAN FRANCISCO (AP) — Northern California was under a rare and brief tsunami warning alert Thursday that tested local emergency notification systems after a 7.0 magnitude earthquake shook part of the state. The National Weather Service canceled its alert after roughly an hour and before the tsunami was expected to arrive. In that hour, some cities and counties ordered evacuations while others relied on social media and text messages to inform people of the warning. Some people headed for higher ground, while others drove to the beach to get a better view. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.(PRNewsfoto/Avidity Biosciences, Inc.) SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCsTM), today announced that on November 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 117,000 shares of its common stock and 58,500 restricted stock units ("RSUs") to twelve (12) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4). The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Avidity, or following a bona fide period of non-employment, as an inducement material to such individuals' entering into employment with Avidity, pursuant to Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $43.65 per share, which is equal to the closing price of Avidity's common stock on The Nasdaq Global Market on November 20, 2024, or the vesting commencement date. The shares subject to the stock options will vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter, subject to each employee's continued employment with Avidity on such vesting dates. The RSUs will vest in four equal installments on the first four anniversaries of the vesting commencement date, subject to each employee's continued employment with Avidity on such vesting dates. The awards are subject to the terms and conditions of the 2022 Inducement Plan and the terms and conditions of a stock option agreement or RSU agreement, as applicable, covering the grant. About Avidity Avidity Biosciences, Inc.'s mission is to profoundly improve people's lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates (AOCsTM). Avidity is revolutionizing the field of RNA with its proprietary AOCs, which are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Utilizing its proprietary AOC platform, Avidity demonstrated the first-ever successful targeted delivery of RNA into muscle and is leading the field with clinical development programs for three rare neuromuscular diseases: myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). Avidity is also advancing two wholly-owned precision cardiology development candidates addressing rare genetic cardiomyopathies. In addition, Avidity is broadening the reach of AOCs with its advancing and expanding pipeline including programs in cardiology and immunology through key partnerships. Avidity is headquartered in San Diego, CA. For more information about our AOC platform, clinical development pipeline and people, please visit www.aviditybiosciences.com and engage with us on LinkedIn and X . Investor Contact: Mike MacLean (619) 837-5014 investors@aviditybio.com Media Contact: Navjot Rai (619) 837-5016 media@aviditybio.com View original content to download multimedia: https://www.prnewswire.com/news-releases/avidity-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302313526.html SOURCE Avidity Biosciences, Inc.
President Moon Jae-in, who has been facing declining approval ratings and mounting criticism over his handling of various issues, now faces increasing pressure to address the public's growing concerns about corruption and governance. With the demand for Yoon's arrest gaining momentum, many see this as a critical moment that could potentially reshape the political landscape in South Korea.
The resolution, once enacted, is expected to authorize law enforcement agencies to take immediate action against Yoon Suk-yeol, potentially leading to his arrest and subsequent legal proceedings. The implications of this development are far-reaching, with some political analysts suggesting that it could culminate in the President's removal from office and trigger early elections in the country.NoneGu Ailing, the rising star in the world of freestyle skiing, made headlines once again over the weekend as she clinched another championship title. Despite her triumph on the slopes, the dedicated athlete wasted no time in returning to her academic pursuits at the prestigious Oxford University on Monday. Netizens were quick to praise her remarkable work ethic and determination, highlighting her ability to seamlessly balance her athletic achievements with her educational pursuits.